• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

NephroGenex Inc

+ Add to Watchlist


6.6500 USD 0.1500 2.21%

As of 20:10:00 ET on 04/17/2014.

Snapshot for NephroGenex Inc (NRX)

Open: 6.4000 Day's Range: 6.4000 - 6.7500 Volume: 3,177
Previous Close: 6.8000 52wk Range: 6.1320 - 13.0000 1-Yr Rtn: -

Stock Chart for NRX

No chart data available.
  • NRX:US 6.6500
  • 1D
  • 1M
  • 1Y
Interactive NRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NRX

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 58.89
Shares Outstanding (M) 8.86
30 Day Average Volume 20,882
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NRX

No data available

Company Profile & Key Executives for NRX

NephroGenex, Inc. develops novel drugs for the treatment of kidney disease. The Company is developing a small molecule drug that acts as an inhibitor of the pathogenic oxidative chemistries which are elevated in diabetic patients.

J Wesley FoxPres/Chief Scientific OfcrPierre LegaultChief Executive Officer
John P HamillChief Financial OfficerBob PetersonVP:Product Dev
More Company Profile & Key Executives for NRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil